Marta Marginet

Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death‐ligand 1 (PD‐L1) axis in post‐transplant lymphoproliferative disorders: association with Epstein–Barr virus, <i>PD‐L1</i> copy number alterations, and outcome

Luis Veloza, Cristina Teixidó, Natalia Castrejón de Anta et al. · Histopathology · 2019 · 30 citations

Medicine, Oncology, Pathology +13

TP53 mutation and tumoral PD-L1 expression are associated with depth of invasion in desmoplastic melanomas

Llúcia Alós, Carla Fuster, Paola Castillo et al. · Annals of Translational Medicine · 2020 · 14 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Implementation of an NGS panel for clinical practice in paraffin-embedded tissue samples from locally advanced and metastatic melanoma patients

Paola Castillo, Marta Marginet, Pedro Jares et al. · Exploration of Targeted Anti-tumor Therapy · 2020 · 11 citations · Full text

Medicine, Molecular Genetics, Oncology +17

HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders

Sandra Sanchez, Luis Veloza, Luojun Wang et al. · International Journal of Hematology · 2020 · 10 citations · Full text

Medicine, Infectious Diseases, Oncology +11